Rizzo Group AB
STO:RIZZO B
Rizzo Group AB
Total Liabilities & Equity
Rizzo Group AB
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
R
|
Rizzo Group AB
STO:RIZZO B
|
Total Liabilities & Equity
kr133.4m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
![]() |
H & M Hennes & Mauritz AB
STO:HM B
|
Total Liabilities & Equity
kr180.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
R
|
RVRC Holding AB
STO:RVRC
|
Total Liabilities & Equity
kr1.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
N
|
New Bubbleroom Sweden AB
STO:BBROOM
|
Total Liabilities & Equity
kr215.5m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
R
|
Refine Group AB (publ)
STO:REFINE
|
Total Liabilities & Equity
kr218m
|
CAGR 3-Years
107%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Rizzo Group AB
Glance View
Rizzo Group AB owns and operates shoe and accessory stores. The company is headquartered in Stockholm, Stockholm. The Company’s activities are divided into two business areas: Accessories and Shoes and has three own brands: Accent, Morris, Rizzo and departments at Nordiska Kompaniet (NK) with own and external brands. The Accessories area is responsible for operating the Accent and Morris store chains and the Shoes business area operates of own (Rizzo) and external brands. Furthermore, the Company operates approximately 101 stores in Sweden and Norway.
See Also
What is Rizzo Group AB's Total Liabilities & Equity?
Total Liabilities & Equity
133.4m
SEK
Based on the financial report for Aug 31, 2023, Rizzo Group AB's Total Liabilities & Equity amounts to 133.4m SEK.
What is Rizzo Group AB's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
-16%
Over the last year, the Total Liabilities & Equity growth was -37%. The average annual Total Liabilities & Equity growth rates for Rizzo Group AB have been -33% over the past three years , -16% over the past five years .